RBM14 and Parkinson disease: Through Western blotting and RT‒qPCR detection, we found that compared with those in the healthy control group, the expression levels of RBM14 and CALR in the PD group were increased, while AGTR1 and XPA were significantly downregulated (Fig. 10).